FrancophonIA/ELRC3.0 huggingface dataset:
English: renal failure (acute and chronic), acute tubular necrosis, nephritis (including acute interstitial nephritis)3, nephrogenic diabetes insipidus
Slovenian: ledvična odpoved (akutna in kronična), akutna tubularna nekroza, nefritis (vključno z akutnim intersticijskim nefritisom)3, nefrogeni insipidusni diabetes
English: If there is evidence of worsening liver disease in such patients, interruption or discontinuation of treatment must be considered.
Slovenian: Če pri teh bolnikih pride do znakov poslabšanja jetrne bolezni, je treba razmisliti o začasni ali trajni prekinitvi zdravljenja.
English: Both emtricitabine and tenofovir have activity that is specific to human immunodeficiency virus (HIV-1 and HIV-2) and hepatitis B virus.
Slovenian: Tako emtricitabin kot tenofovir imata aktivnost, ki je specifična za humani virus imunske pomanjkljivosti (HIV-1 in HIV-2) in virus hepatitisa B.
English: Emtricitabine/tenofovir disoproxil should only be used for pre-exposure prophylaxis as part of an overall HIV-1 infection prevention strategy including the use of other HIV-1 prevention measures (e.g. consistent and correct condom use, knowledge of HIV-1 status, regular testing for other sexually transmitted infections).
Slovenian: Emtricitabin/dizoproksiltenofovirat se sme uporabljati le za zaščito pred izpostavitvijo kot del splošne strategije za preprečevanje okužbe s HIV-1, vključno z uporabo drugih ukrepov za preprečevanje okužbe s HIV-1 (npr. dosledna in pravilna uporaba kondoma, poznavanje statusa okužbe s HIV-1, redno testiranje za druge spolno prenosljive okužbe).
English: Relevant examples are cytomegalovirus retinitis, generalised and/or focal mycobacterial infections, and Pneumocystis jirovecii pneumonia.
Slovenian: Ustrezni primeri so citomegalovirusni retinitis, generalizirane in/ali žariščne okužbe z mikobakterijami in s Pneumocystis jirovecii povzročena pljučnica.
English: If concomitant use with nephrotoxic agents is unavoidable, renal function should be monitored weekly.
Slovenian: Če je sočasna uporaba z nefrotoksičnim zdravilom neizogibna, je treba tedensko nadzirati ledvično funkcijo.
English: • Reminder of factors to help identify individuals at high risk of acquiring HIV-1
Slovenian: • opozorilo za dejavnike, ki pomagajo določiti posameznike z visokim tveganjem za okužbo s HIV-1;
English: In vitro studies have determined that neither tenofovir disoproxil nor tenofovir are substrates for the CYP450 enzymes.
Slovenian: In vitro študije so pokazale, da niti dizoproksiltenofovirat niti tenofovir nista substrata za CYP450 encime.
English: The most frequent adverse reaction reported in the emtricitabine/tenofovir disoproxil group in the iPrEx study was headache (1%).
Slovenian: Najpogostejši neželeni učinek, o katerem so poročali v skupini, ki je prejemala emtricitabin/dizoproksiltenofovirat v študiji iPrEx, je bil glavobol (1 %).
English: Use of tenofovir disoproxil may cause a reduction in BMD.
Slovenian: Uporaba dizoproksiltenofovirata lahko povzroči zmanjšanje MKG.
English: Maximum emtricitabine and tenofovir concentrations are observed in serum within 0.5 to 3.0 h of dosing in the fasted state.
Slovenian: Najvišje koncentracije emtricitabina in tenofovirja so opažene v serumu znotraj 0,5 ure do 3,0 ur po zaužitju na tešče.
English: In infants and children older than 4 months, the majority of patients taking emtricitabine achieved or maintained complete suppression of plasma HIV 1 RNA through 48 weeks (89% achieved ≤ 400 copies/mL and 77% achieved ≤ 50 copies/mL).
Slovenian: Pri dojenčkih in otrocih, starejših od 4 mesece, je večina bolnikov, ki je jemala emtricitabin, dosegla ali ohranila popolno supresijo plazemske HIV-1 RNA do konca 48. tedna (89 % je doseglo ≤ 400 kopij/ml in 77 % je doseglo ≤ 50 kopij/ml).
English: Among them, 3 patients experienced a clinically meaningful decline in estimated GFR during therapy which improved after discontinuation of tenofovir disoproxil.
Slovenian: Med njimi se je pri 3 bolnikih med zdravljenjem pojavilo klinično pomembno zmanjšanje ocenjene vrednosti GFR, ki se je po ukinitvi dizoproksiltenofovirata izboljšala.
English: rhabdomyolysis1, muscular weakness1
Slovenian: rabdomioliza1, mišična oslabelost1
English: The bone toxicity in young adult rats and dogs occurred at exposures ≥ 5-fold the exposure in paediatric or adult patients; bone toxicity occurred in juvenile infected monkeys at very high exposures following subcutaneous dosing (≥ 40-fold the exposure in patients).
Slovenian: Toksičen vpliv na kosti pri mladih odraslih podganah in psih se je pojavil pri ≥ 5-kratni izpostavljenosti za pediatrične ali odrasle bolnike; toksičen vpliv na kosti se je pojavil pri mladih okuženih opicah pri zelo visokih izpostavljenostih po subkutanemu dajanju (≥ 40-kratna izpostavljenost pri bolnikih).
English: The biotransformation of emtricitabine includes oxidation of the thiol moiety to form the 3'-sulphoxide diastereomers (approximately 9% of dose) and conjugation with glucuronic acid to form 2'-O-glucuronide (approximately 4% of dose).
Slovenian: Biotransformacija emtricitabina vključuje oksidacijo tiolnega dela molekule, pri čemer nastanejo 3'-sulfoksid diastereomere (približno 9 % odmerka) in konjugacijo z glukuronsko kislino, pri čemer nastane 2'-O-glukuronid (približno 4 % odmerka).
English: The apparent clearance of tenofovir averaged approximately 307 mL/min.
Slovenian: Navidezni očistek tenofovirja je povprečno znašal približno 307 ml/min.
English: No data are available to make dose recommendations (see sections 4.2 and 4.4).
Slovenian: Podatki za dajanje priporočil o odmerjanju niso na voljo (glejte poglavji 4.2 in 4.4).
English: • enlarged lymph nodes in the neck or groin  Tell your doctor about any flu-like illness - either in the month before starting this medicine, or at any time while taking this medicine.
Slovenian: • povečane bezgavke v vratu ali dimljah  Svojega zdravnika obvestite, če se pojavi gripi podobna bolezen - ali v zadnjem mesecu pred začetkom jemanja ali kadar koli med jemanjem tega zdravila.
English: Emtricitabine/tenofovir disoproxil is not always effective in preventing the acquisition of HIV-1.
Slovenian: Emtricitabin/dizoproksiltenofovirat ni vedno učinkovit pri preprečevanju okužbe s HIV-1.
English: Following oral administration, the elimination half-life of tenofovir is approximately 12 to 18 hours.
Slovenian: Po peroralni uporabi zdravila je razpolovna doba izločanja tenofovirja približno 12 do 18 ur.
English: It is not known whether emtricitabine or tenofovir can be removed by peritoneal dialysis.
Slovenian: Ni znano, ali se lahko emtricitabin oziroma tenofovir odstranita s peritonealno dializo.
English: If you have taken Emtricitabine/Tenofovir disoproxil Mylan during your pregnancy, your doctor may request regular blood tests and other diagnostic tests to monitor the development of your child.
Slovenian: Če ste zdravilo Emtricitabin/dizoproksiltenofovirat Mylan jemali med nosečnostjo, vas lahko zdravnik naroči na redne preiskave krvi in druge diagnostične preiskave, da bo spremljal razvoj vašega otroka.
English: Use for pre-exposure prophylaxis in individuals with unknown or positive HIV-1 status.
Slovenian: Uporaba za zaščito pred izpostavitvijo pri posameznikih z neznanim ali pozitivnim statusom okužbe s HIV-1.
English: • If you are a woman with HIV it is recommended that you do not breast-feed, to avoid passing the virus to the baby in breast milk.
Slovenian: • Če ste ženska, okužena z virusom HIV, je priporočljivo, da ne dojite, da s tem preprečite prenos virusa preko mleka na dojenčka.
English: There have been reports of mitochondrial dysfunction in HIV negative infants exposed in utero and/or postnatally to nucleoside analogues; these have predominantly concerned treatment with regimens containing zidovudine.
Slovenian: Obstajajo poročila o mitohondrijski disfunkciji pri HIV-negativnih dojenčkih, ki so bili in utero in/ali postnatalno izpostavljeni nukleozidnim analogom; ta so pretežno zadevala zdravljenje z režimi, ki vsebujejo zidovudin.
English: Reproductive toxicity studies in rats and rabbits showed no effects on mating, fertility, pregnancy or foetal parameters.
Slovenian: Študije o vplivu na sposobnost razmnoževanja na podganah in zajcih niso pokazale učinkov na parjenje, plodnost, nosečnost ali plod.
English: As a general rule, it is recommended that HIV infected women do not breast-feed their infants under any circumstances in order to avoid transmission of HIV to the infant.
Slovenian: Splošno priporočilo je, naj s HIV okužene ženske v nobenem primeru ne dojijo, da se prepreči prenos HIV na dojenčka.
English: Stopping use of this medicine, or missing doses, may increase your risk of getting HIV infection.
Slovenian: Prenehanje uporabe tega zdravila ali izpuščeni odmerki lahko povečajo tveganje za pridobitev okužbe s HIV.
English: • increased creatinine in your blood
Slovenian: • povišan kreatinin v krvi
English: Patients infected with HBV who discontinue emtricitabine/tenofovir disoproxil therapy should be closely monitored with both clinical and laboratory follow-up for at least several months after stopping treatment.
Slovenian: Bolniki z okužbo s HBV, ki prekinejo zdravljenje z emtricitabinom/dizoproksiltenofoviratom, potrebujejo natančno spremljanje z ustreznimi kliničnimi in laboratorijskimi preiskavami še vsaj nekaj mesecev po prenehanju zdravljenja.
English: In individuals at risk for renal disease more frequent monitoring of renal function is required.
Slovenian: Pri posameznikih z dejavniki tveganja za okvaro ledvic je potrebno pogostejše spremljanje delovanja ledvic.
English: • other allergic reactions, such as wheezing, swelling or feeling light-headed
Slovenian: • druge alergijske reakcije, kot so piskanje, otekanje ali omotičnost
English: • breakdown of muscle, muscle pain or weakness which may occur due to damage to the kidney tubule cells
Slovenian: • razpad mišičnega tkiva, bolečine v mišicah ali mišična oslabelost, ki se lahko pojavi zaradi poškodovanja celic ledvičnih tubulov
English: This medicine is not a cure for HIV infection.
Slovenian: Zdravilo ne ozdravi okužbe z virusom HIV.
English: b Relative risk reduction calculated for mITT based on incident seroconversion, ie, occurring post-baseline through first posttreatment visit (approximately 1 month after last study drug dispensation).
Slovenian: b Relativno zmanjšanje tveganja, izračunano za mITT na osnovi dogodka serokonverzije, tj. pojava po izhodišču študije do prvega obiska po zdravljenju (približno 1 mesec po prejemu zadnjega odmerka preiskovanega zdravila).
English: In vitro studies have shown that both emtricitabine and tenofovir can be fully phosphorylated when combined together in cells.
Slovenian: In vitro študije so pokazale, da se lahko tako emtricitabin kot tenofovir popolnoma fosforilirata v celicah, ko se uporabita v kombinaciji.
English: • rashes (including red spots or blotches sometimes with blistering and swelling of the skin), which may be allergic reactions, itching, changes in skin colour including darkening of the skin in patches
Slovenian: • izpuščaji (vključno z rdečimi pikami ali ogrci, včasih z mehurjasto in oteklo kožo), kar je lahko alergijska reakcija, srbečica, sprememba obarvanosti kože, vključujoč temne lise
English: Seven patients had estimated glomerular filtration rate (GFR) values between 70 and 90 mL/min/1.73 m2.
Slovenian: Sedem bolnikov je imelo ocenjene vrednosti hitrosti glomerularne filtracije (GFR, glomerular filtration rate) med 70 in 90 ml/min/1,73 m².
English: Didanosine/Emtricitabine
Slovenian: didanozin/emtricitabin
English: Number with Tenofovir Detected/ Total Samples (%)
Slovenian: Število zaznanih primerov tenofovirja/skupno vzorci (%)
English: In general, emtricitabine pharmacokinetics in HBV infected subjects were similar to those in healthy subjects and in HIV infected patients.
Slovenian: Na splošno so bile farmakokinetične lastnosti emtricitabina pri osebah, okuženih z virusom HBV zelo podobne tistim pri zdravih osebah in bolnikih, okuženih z virusom HIV.
English: Female
Slovenian: Ženski
English: Pre-exposure prophylaxis (PrEP):
Slovenian: Zaščita pred izpostavitvijo (Pre-exposure prophylaxis - PrEP):
English: Seroconversions / N
Slovenian: Serokonverzija/N
English: Emtricitabine/tenofovir disoproxil should only be used in individuals with creatinine clearance (CrCl) <80 mL/min if the potential benefits are considered to outweigh the potential risks.
Slovenian: Zdravilo Emtricitabin/dizoproksiltenofovirat Mylan se sme uporabljati samo pri posameznikih z očistkom kreatinina (CrCl) < 80 ml/min, če se oceni, da morebitne koristi odtehtajo morebitna tveganja.
English: Combination of emtricitabine and tenofovir disoproxil: Genotoxicity and repeated dose toxicity studies of one month or less with the combination of these two components found no exacerbation of toxicological effects compared to studies with the separate components.
Slovenian: Kombinacija emtricitabina in dizoproksiltenofovirata: V študijah genotoksičnosti ali študijah s ponavljajočim se odmerkom, ki so trajale en mesec ali manj z uporabo kombinacije teh dveh učinkovin niso ugotovili poslabšanja toksikoloških vplivov, v primerjavi s posameznima učinkovinama.
English: The film-coated tablet can be disintegrated in approximately 100 mL of water, orange juice or grape juice and taken immediately.
Slovenian: Filmsko obloženo tableto se lahko raztopi v približno 100 ml vode, pomarančnega ali grozdnega soka.
English: • Bone problems.
Slovenian: • Težave s kostmi.
English: • Take this medicine every day to reduce your risk, not just when you think you have been at risk of HIV infection.
Slovenian: • To zdravilo vzemite vsak dan, da zmanjšate tveganje, in ne le takrat, ko menite, da obstaja tveganje za okužbo z virusom HIV.
English: Renal and bone effects in the paediatric population
Slovenian: Učinki na kosti in ledvice pri pediatrični populaciji
English: The safety profile of emtricitabine and tenofovir disoproxil in this study was consistent with the previous experience with these agents when each was administered with other antiretroviral agents.
Slovenian: Varnostni profil emtricitabina in dizoproksiltenofovirata v tej študiji je bil skladen s predhodnimi izkušnjami s tema učinkovinama, ko so bolniki vsako od njiju prejemali z drugimi protiretrovirusnimi zdravili.
English: • Talk to your doctor if you are over 65.
Slovenian: • Če ste starejši od 65 let, se posvetujte z zdravnikom.
English: Findings in the rat and monkey studies indicated that there was a substance-related decrease in intestinal absorption of phosphate with potential secondary reduction in BMD.
Slovenian: Rezultati študij izvedenih na podganah in opicah so pokazala z učinkovino povezano zmanjšanje absorpcije fosfata v črevesju s potencialno sekundarnim zmanjšanjem BMD.
English: If you are taking another antiviral medicine called a protease inhibitor to treat HIV, your doctor may order blood tests to closely monitor your kidney function.
Slovenian: Če za zdravljenje HIV jemljete drugo protivirusno zdravilo, ki se imenuje zaviralec proteaze, bo vaš zdravnik morda naročil krvne preiskave z namenom natančnega spremljanja delovanja vaših ledvic.
English: The 48-week primary endpoint data showed that the combination of emtricitabine, tenofovir disoproxil and efavirenz provided superior antiviral efficacy as compared with the fixed combination of lamivudine and zidovudine with efavirenz as shown in Table 4.
Slovenian: Podatki za primarni cilj po 48 tednih so pokazali, da je imela kombinacija emtricitabina, dizoproksiltenofovirata in efavirenza večjo protivirusno učinkovitost kot fiksna kombinacija lamivudina in zidovudina z efavirenzom, kot je prikazano v preglednici 4.
English: Patients with hepatitis B or C virus infection
Slovenian: Bolniki, okuženi z virusom hepatitisa B ali C
English: elevated serum aspartate aminotransferase (AST) and/or elevated serum alanine aminotransferase (ALT), hyperbilirubinaemia increased transaminases
Slovenian: zvišana serumska aspartataminotransferaza (AST) in/ali zvišana serumska alanin-aminotransferaza (ALT), hiperbilirubinemija povišane transaminaze
English: • deep rapid breathing
Slovenian: • globoko, hitro dihanje
English: Additional risk minimisation measures
Slovenian: • Dodatni ukrepi za obvladovanje tveganja
English: In some patients with advanced HIV infection (AIDS) and a history of opportunistic infections (infections that occur in people with a weak immune system), signs and symptoms of inflammation from previous infections may occur soon after anti-HIV treatment is started.
Slovenian: Pri nekaterih bolnikih z napredovalo okužbo s HIV (AIDS) in preteklimi oportunističnimi okužbami (okužbe, do katerih pride pri ljudeh s šibkim imunskim sistemom) se lahko pojavijo vnetni znaki in simptomi preteklih okužb po začetku zdravljenja okužbe s HIV.
English: Gender, N (%) Male
Slovenian: Spol, N (%)
English: The incidences of HIV seroconversion overall and in the subset reporting unprotected receptive anal intercourse are shown in Table 6.
Slovenian: Pojavnosti serokonverzije HIV na splošno in v podskupini (nezaščiten receptivni analni spolni odnos) sta prikazani v preglednici 6.
English: The difference in the proportion of patients who maintained < 400 copies/mL at week 48 was mainly influenced by the higher number of discontinuations in the tenofovir disoproxil treatment group.
Slovenian: Na razliko v deležu bolnikov, ki so ohranili < 400 kopij/ml v 48. tednu, so pretežno vplivale prekinitve v skupini zdravljenja z dizoproksiltenofoviratom.
English: In addition to the adverse reactions reported in adults, anaemia (9.5%) and skin discolouration (31.8%) occurred more frequently in clinical trials in paediatric patients than in adults (see section 4.8, Tabulated summary of adverse reactions).
Slovenian: Poleg neželenih učinkov, o katerih so poročali pri odraslih, sta se anemija (9,5 %) in obarvanje kože (31,8 %) pogosteje pojavljala v kliničnih preskušanjih pri pediatričnih bolnikih kot pri odraslih (glejte poglavje 4.8, Povzetek neželenih učinkov, prikazan v preglednici).
English: If you have kidney problems, your doctor may advise you to stop taking emtricitabine/tenofovir disoproxil or, if you already have HIV, to take emtricitabine/tenofovir disoproxil less frequently.
Slovenian: Če imate ledvične težave, vam zdravnik lahko svetuje, da emtricitabin/dizoproksiltenofovirat prenehate jemati ali, če ste že okuženi s HIV, da emtricitabin/dizoproksiltenofovirat uporabljate manj pogosto.
English: McDermott Laboratories Limited T/A Gerard Laboratories T/A Mylan Dublin 35/36 Baldoyle Industrial Estate, Grange Road, Dublin 13 Ireland
Slovenian: McDermott Laboratories Limited T/A Gerard Laboratories T/A Mylan Dublin 35/36 Baldoyle Industrial Estate, Grange Road, Dublin 13 Irska
English: Table 2: Interactions between emtricitabine/tenofovir disoproxil or its individual component(s) and other medicinal products
Slovenian: Preglednica 2: Interakcije med emtricitabinom/dizoproksiltenofoviratom ali njegovo(-imi) posamično(-imi) učinkovino(-ami) in drugimi zdravili
English: • Emtricitabine/Tenofovir disoproxil Mylan is also used to reduce the risk of getting HIV-1 infection in adults, and adolescents aged 12 years to less than 18 years who weigh at least 35 kg, when used as a daily treatment, together with safer sex practices:
Slovenian: • Zdravilo Emtricitabin/dizoproksiltenofovirat Mylan se uporablja tudi za zmanjšanje tveganja za okužbo z virusom HIV-1 pri odraslih in mladostnikih, starih od 12 do 18 let, ki tehtajo vsaj 35 kg, kadar se uporablja za vsakodnevno zdravljenje, ob hkratnem upoštevanju varnega spolnega vedenja:
English: • If you have hepatitis B, it is especially important not to stop your treatment with Emtricitabine/Tenofovir disoproxil Mylan without talking to your doctor first.
Slovenian: • Če ste okuženi s hepatitisom B, je še zlasti pomembno, da ne prenehate z zdravljenjem z zdravilom Emtricitabin/dizoproksiltenofovirat Mylan, ne da bi se prej posvetovali z zdravnikom.
English: The systemic clearance of emtricitabine averaged 307 mL/min.
Slovenian: Sistemski očistek emtricitabina je v povprečju 307 ml/min.
English: Following intravenous administration, the volume of distribution of emtricitabine and tenofovir was approximately 1.4 L/kg and 800 mL/kg, respectively.
Slovenian: Po intravenskem odmerku je volumen porazdelitve emtricitabina znašal približno 1,4 l/kg in volumen porazdelitve tenofovirja približno 800 ml/kg.
English: Adherence Substudy Participantsb Placebo
Slovenian: Sodelujoči v podštudiji adherenceb Placebo
English: A small clinical study was conducted to evaluate the safety, antiviral activity and pharmacokinetics of tenofovir disoproxil in combination with emtricitabine in HIV infected patients with renal impairment.
Slovenian: Izvedena je bila majhna klinična študija za ocenitev varnosti, protivirusne aktivnosti in farmakokinetike dizoproksiltenofovirata v kombinaciji z emtricitabinom pri bolnikih, okuženih z virusom HIV z ledvično okvaro.
English: insomnia, abnormal dreams
Slovenian: nespečnost, nenavadne sanje
English: Following oral administration, the elimination half-life of emtricitabine is approximately 10 hours.
Slovenian: Po peroralni uporabi zdravila je razpolovna doba izločanja emtricitabina približno 10 ur.
English: For monitoring of blood lipids and glucose reference is made to established HIV treatment guidelines.
Slovenian: Za nadzor lipidov in glukoze v krvi je treba upoštevati veljavne smernice za zdravljenje okužbe z virusom HIV.
English: Emtricitabine is primarily excreted by the kidneys with complete recovery of the dose achieved in urine (approximately 86%) and faeces (approximately 14%).
Slovenian: Emtricitabin se primarno izloča preko ledvic - celoten odmerek se izolira iz urina (približno 86 %) in iz blata (približno 14 %).
English: These findings should be considered for any child exposed in utero to nucleos(t)ide analogues, who present with severe clinical findings of unknown etiology, particularly neurologic findings.
Slovenian: Te ugotovitve je treba upoštevati pri vseh otrocih, ki so bili in utero izpostavljeni nukleozidnim in nukleotidnim analogom, pri katerih se pojavijo resne klinične ugotovitve neznanega vzroka, še zlasti nevrološke.
English: Exacerbations of hepatitis after discontinuation of treatment: In HBV infected patients, clinical and laboratory evidence of hepatitis have occurred after discontinuation of treatment (see section 4.4).
Slovenian: Poslabšanje hepatitisa po prekinitvi zdravljenja: Pri bolnikih, okuženih z virusom HBV, so se po prekinitvi zdravljenja pokazali klinični in laboratorijski znaki hepatitisa (glejte poglavje 4.4).
English: However, as would be expected in this patient population, elevations in AST and ALT occurred more frequently than in the general HIV infected population.
Slovenian: Vendar je pri teh bolnikih, kot pričakovano, pogostejši porast AST in ALT, kot pri bolnikih, okuženih samo z virusom HIV.
English: The frequency category was estimated from a statistical calculation based on the total number of patients exposed to emtricitabine in randomised controlled clinical studies (n = 1,563) or tenofovir disoproxil in randomised controlled clinical trials and the expanded access program (n = 7,319).
Slovenian: Kategorija pogostnosti je bila ocenjena s statističnim izračunom na podlagi skupnega števila bolnikov, izpostavljenih emtricitabinu v randomiziranih kontroliranih kliničnih študijah (n = 1.563) ali dizoproksiltenofoviratu v randomiziranih kontroliranih kliničnih študijah in podaljšanem programu dostopanja (n = 7.319).
English: • If you are an adult taking this medicine to reduce the risk of getting HIV, take this medicine every day, not just when you think you have been at risk of HIV infection.
Slovenian: • Če ste odrasli in to zdravilo jemljete za zmanjšanje tveganja za okužbo s HIV, jemljite to zdravilo vsak dan, ne le takrat, ko menite, da obstaja tveganje za okužbo z virusom HIV.
English: Both of these active substances are antiretroviral medicines which are used to treat HIV
Slovenian: Obe zdravilni učinkovini sta protiretrovirusni zdravili, ki se uporabljata za zdravljenje okužbe z virusom HIV.